Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
1
x
$
30.00
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
1
x
$
0.00
Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
1
x
$
30.00
Assessing Rates and Predictors of Tachyphylaxis
1
x
$
30.00
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
1
x
$
30.00
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
1
x
$
30.00
View Cart
Checkout
Home
Rana AL-Jumah
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Treatment of Fibromyalgia: A Comprehensive Clinical Review
$
30.00
Add to cart
Details
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
$
30.00
Add to cart
Details
Page load link
Go to Top